Tag: Novartis

Novartis Chief Medical Officer John Tsai on Balancing Medical Innovations With Patient Needs

Originally published at novartis.com by Elizabeth Dougherty. John Tsai is Novartis’ Head of Global Drug Development and Chief Medical Officer. Novartis Pharmaceuticals is a DiversityInc Hall of Fame company.   John Tsai’s career as a physician, and now as Head of Global Drug Development and Chief Medical Officer for Novartis, had an unlikely…

Novartis Collaborates With Microsoft To Innovate Medicine Through Data and Artificial Intelligence

Originally published on LinkedIn. Novartis Pharmaceuticals is a DiversityInc Hall of Fame company.   “We are not just discoverers. We actually create molecules that have never been made before.” Says Karin Briner, Head of Global Discovery Chemistry at Novartis Institutes for BioMedical Research (NIBR). By collaborating with Microsoft and augmenting the expertise of our…

Novartis Pharmaceuticals’ Statement on COVID-19 Vaccinations and Enabling Its Associates To Work On-Site Safely

Originally published at novartis.com. Novartis Pharmaceuticals is a DiversityInc Hall of Fame company.   As a leading healthcare company, Novartis is playing an important part by supporting vaccination to help overcome the pandemic. The safety of all associates, our customers, business partners and the communities where we run our operations…

Novartis Pharmaceuticals on World Sight Day 2021

Originally published at novartis.com. Novartis Pharmaceuticals is a DiversityInc Hall of Fame company.   Many of us will experience some kind of eye health issue in our lifetime, but did you know that more than 1 billion people worldwide do not have access to the eye health care they need?…

Novartis on 5 of the Company’s Key ESG Achievements in 2021

Originally published on LinkedIn. Novartis Pharmaceuticals is a DiversityInc Hall of Fame company.   Novartis Pharmaceuticals is accelerating its journey toward expanding access to medicines, improving health equity, and achieving a zero-carbon future. ESG is central to the Novartis strategy and is key to delivering long-term value to patients, providers,…